Epoetin alfa
Epogen/Procrit, Procrit (epoetin alfa) is a protein pharmaceutical. Epoetin alfa was first approved as Epogen/Procrit on 1989-06-01. It is used to treat anemia in the USA. It has been approved in Europe to treat anemia, chronic kidney failure, and neoplasms. It is known to target erythropoietin receptor.
| Trade Name | Epogen/Procrit, Procrit |
|---|---|
| Common Name | Epoetin alfa |
| Indication | anemia, chronic kidney failure, neoplasms |
| Drug Class | Erythropoietins |
